Cunningham Timothy M. 4
4 · Organogenesis Holdings Inc. · Filed Dec 12, 2018
Insider Transaction Report
Form 4
Cunningham Timothy M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-12-10+559,620→ 559,620 totalExercise: $3.46Exp: 2027-05-04→ Common Stock (559,620 underlying)
Footnotes (2)
- [F1]The shares underlying the option vested or shall vest 20% annually beginning on August 22, 2016.
- [F2]Received in connection with the Issuer's business combination (the "Merger") with Organogenesis Inc. ("Organogenesis") in accordance with the terms of the Agreement and Plan of Merger dated as of August 17, 2018 among the Issuer, which was then referred to as Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, in exchange for an option to acquire 275,675 shares of common stock of Organogenesis for $7.01 per share.